May 7, 2026
Shukra Pharmaceuticals Q1 FY26 Net Profit ₹36.75m
SHUKRA PHARMACEUTICALS LIMITED — Quarter ended 31 March 2026 (Audited) and Year ended 31 March 2026 (Audited) Optional commentary: The document includes standalone and consolidated audited...
